Skip to main content

Fact or Fiction: Healthcare Big Data

Bill Geary (North Bridge, Humedica, Healthrageous), Michael Weintraub (Humedica), Chris Kryder (D2 Hawkeye and Chairman, Valence Health), Charlie Baker (General Catalyst Partners)
Deal-Flow Salon G
Average rating: ***..
(3.00, 1 rating)

A vibrant discussion about the use of healthcare data to change the cost curve, increase revenues, when does an organization have enough data sufficient to act, mining your own information and using outside solutions providers

Photo of Bill Geary

Bill Geary

North Bridge, Humedica, Healthrageous

Bill Geary has been with North Bridge since its inception in 1994, a leading early-stage venture capital and growth equity investment firm with over $3B under management. Prior to North Bridge, he was a partner at Hambro International Equity Partners. From 1987 to 1990, Bill served as the CFO of MathSoft, an applications software start-up that subsequently went public on the NASDAQ and was later acquired by Parametric Technology Corporation. He focuses his investing primarily on healthcare technology and software, having served on the Boards of Directors of numerous market-leading companies. North Bridge investments include Humedica, Healthrageous, Connance, Valence Health, SynapDx, Aushon Biosystems, 480 Biomedical, Infomedics, Phase Forward, Pharmetrics, NaviNet, eBenX and Arsenal Medical. A graduate of Boston College’s Carroll School of Management Honors Program in 1980, Bill formerly served as the University’s Chair of the Board of Trustees, and is a member of its Investment & Endowment Committee. Additionally, Bill was National Chair of the Duke University Parents Committee and currently serves on the Advisory Boards of the Center For Connected Health at Boston’s Partners HealthCare System, the Technology Fund of Children’s Hospital of Boston, and the Joslin Diabetes Center.

Photo of Michael Weintraub

Michael Weintraub

Humedica

Michael is Founder and CEO of Humedica, recently acquired by UnitedHealth Group. Prior to launching Humedica, Michael served as Senior Managing Director at Leerink Swann, a leading health care investment bank. Previously, he was President and CEO of PHARMetrics, a health care informatics company, which was successfully sold to IMS Health in 2005. Michael has more than 30 years of experience in health care technology, information services, and analytics. Michael serves as Chairman of the Board of Phreesia, a software company that develops automated patient check-in tools, and sits on the board of Anceta, the medical informatics subsidiary of the American Medical Group Association (AMGA). Michael is a member of the Board of Directors of JDRF New England Chapter – Bay State Branch. In 2010, Michael was selected to participate in 12×12, a Massachusetts initiative to multiply entrepreneurship by engaging the creativity and experience of 12 of the state’s leading CEO’s and 12 venture capitalists. Michael received his MBA from Harvard Business School and his bachelor’s degree in Economics from Brandeis University.

Photo of Chris Kryder

Chris Kryder

D2 Hawkeye and Chairman, Valence Health

Chris Kryder, M.D., non-executive Board Chair. Dr. Kryder founded D2Hawkeye in 2000 and was CEO until early 2009, when he sold his firm to ISO, merging health care Information technology assets to form Verisk Health. ISO companies went public as Verisk Analytics (NASDAQ:VRSK) in late 2009. He remained CEO of Verisk Health until January 2011. Verisk Health, nee D2Hawkeye, provides healthcare data analytics and predictive modeling services to large medical groups, health plans, and employers. The company’s products are used to manage clinical and financial risk. In 2008, Dr. Kryder co-founded Generation Health. Generation Health was the first ‘GBM’ (Genetic-testing Benefits Manager), and was focused exclusively on genomics and personalized medicine. Generation Health was sold to CVS Caremark in early 2010. Dr. Kryder received his B.A. from the University of Buffalo, his M.D. from Georgetown University, and his MBA from the Massachusetts Institute of Technology. He completed his internal medicine (primary care) medical residency at Harvard, and maintained his primary care medical practice at MIT until the late 1990s. He has been active on the faculty of Harvard Medical School, Division of Health, Science, and Technology for over twenty-five years.
Photo of Charlie Baker

Charlie Baker

General Catalyst Partners

As an Entrepreneur in Residence at General Catalyst Partners, Charlie Baker focuses on investing in mid-size firms, primarily in the health care services industries.

Before joining General Catalyst, Charlie was the Republican nominee for Governor, losing a close four way race to Massachusetts Governor Deval Patrick. Before that, he spent ten years as CEO of Harvard Pilgrim Health Care, a $2 billion, 1 million member health benefits plan serving individuals and employers in MA, NH and ME. Under his leadership, HPHC went from state receivership to #1 in the country for six years in a row for member satisfaction and clinical effectiveness.

Prior to that, Charlie served as CEO of Harvard Vanguard Medical Associates, the largest independent multi-specialty physician practice in Eastern Massachusetts. In the 1990s, he served as Secretary of Health and Human Services and Secretary of Administration and Finance under Massachusetts Governors Bill Weld and Paul Cellucci, where he earned the Distinguished Service Award from the National Governor’s Association.

For exhibition and sponsorship opportunities at Strata Rx conference, contact Sharon Pierce at (203) 304-9476 or spierce@oreilly.com

For information on trade opportunities with O'Reilly conferences email mediapartners
@oreilly.com

View a complete list of Strata Rx 2013 contacts